{
    "output": [
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Bid",
            "Ablynx",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Reject",
            "Novo Nordisk",
            "ORG/GOV"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Offer",
            "2.6 billion euros",
            "ECON_INDICATOR"
        ],
        [
            "Ablynx",
            "ORG",
            "Specialize",
            "Nano-bodies",
            "CONCEPT"
        ],
        [
            "Nano-bodies",
            "CONCEPT",
            "Found",
            "Llamas and alpacas",
            "ANIMAL"
        ],
        [
            "Ablynx",
            "ORG",
            "Partners",
            "Worlds largest pharmaceutical companies",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Attracted",
            "Ablynxs experimental drug caplacizumab",
            "PRODUCT"
        ],
        [
            "Caplacizumab",
            "PRODUCT",
            "For",
            "Rare bleeding disorder acquired thrombotic thrombocytopenic purpura",
            "CONCEPT"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Has",
            "20 percent of sales",
            "ECON_INDICATOR"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Struggling",
            "Maintain growth momentum in biopharma",
            "SECTOR"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Pay",
            "28.00 euros per share",
            "ECON_INDICATOR"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Additional",
            "2.50 euros in a CVR",
            "CONCEPT"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "First acquisition",
            "Under Lars Fruergaard Jorgensen",
            "PERSON"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Approached",
            "Global Blood Therapeutics",
            "ORG"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Discuss",
            "Potential takeover",
            "CONCEPT"
        ],
        [
            "Novo Nordisk",
            "ORG/GOV",
            "Regrets",
            "Ablynx declined to engage in discussions",
            "CONCEPT"
        ],
        [
            "Jefferies",
            "ORG",
            "Fair value",
            "Ablynx at 29 euros per share",
            "ECON_INDICATOR"
        ],
        [
            "Jefferies",
            "ORG",
            "Long term upside scenario",
            "Ablynx at 36 euros",
            "ECON_INDICATOR"
        ],
        [
            "Jefferies",
            "ORG",
            "Envision",
            "Novo needing to hike the offer",
            "CONCEPT"
        ],
        [
            "Jefferies",
            "ORG",
            "Envision",
            "Counterbids",
            "CONCEPT"
        ],
        [
            "Belgium",
            "GPE",
            "Thriving biotech industry",
            "Many companies spun off from university projects",
            "ORG"
        ],
        [
            "Ablynx",
            "ORG",
            "Listed",
            "Belgiums stock exchange",
            "GPE"
        ],
        [
            "Ablynx",
            "ORG",
            "Shares have almost doubled",
            "Past 12 months",
            "TIME"
        ],
        [
            "Ablynx",
            "ORG",
            "Products",
            "Undergoing medical trials",
            "CONCEPT"
        ],
        [
            "Ablynx",
            "ORG",
            "Target",
            "Many different diseases",
            "CONCEPT"
        ],
        [
            "Evercore",
            "ORG",
            "Advising",
            "Novo",
            "ORG/GOV"
        ],
        [
            "JPMorgan",
            "ORG",
            "Working",
            "Ablynx",
            "ORG"
        ]
    ]
}